newsfilter
← Latest News
PR Newswire·

Aeglea BioTherapeutics Announces Reverse Stock Split

WALTHAM, Mass., Sept. 7, 2023 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea") (NASDAQ:AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with the potential to transform the